Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Sutter Solano Medical Plans Bay Area Projects
Sutter Solano Medical Center is planning a new outpatient care facility in Fairfield, Calif. The not-for-profit community hospital will also improve its Vallejo hospital's emergency department. Sutter Solano is a member of the Sutter Health network, which has planned to invest $3.5-billion in healthcare facilities through the next fifteen years.
Viral Antigens Builds Biologic Manufacturing Facility
Viral Antigens is developing a 2,500-sf biologic manufacturing facility attached to the company's existing Memphis facility. After eighteen months of planning and construction, the final certification of the $2.5-million contract factory will begin. The plant will manufacture proteins and other products, providing clean-room production for smaller biotech companies and researchers still in Phase I development.
Cephalon Seeks New Research Facilities
Cephalon is seeking 100 acres on which to locate a research and office complex that could eventually total up to 1,000,000 sf. Currently housed in 160,000 sf in West Chester, Cephalon's research and administrative operations employ 400 workers. The biotech company prefers to remain in the Philadelphia area, but is also considering locations in Collegeville, Montgomery County, and in northern Delaware. Cephalon has contracted the local office of Julien J. Studley Inc. to provide site selection and planning services.
Novellus Expands Oregon Operations
San Jose-based semiconductor equipment maker Novellus Systems is expanding its Tualatin, Oregon, operations with the opening of a 382,000-sf plant. Located on a 58-acre campus, the factory will manufacture products for chipmakers to produce advanced integrated circuits, including Novellus' copper metallization and damascene dielectric deposition tools.
Diosynth Plans Manufacturing Expansion
Netherlands-based pharmaceutical company Diosynth is planning a two-phase purchase of 91.3 acres in Research Triangle Park (RTP) with plans to add over 300,000 sf of new manufacturing space. Diosynth's purchase of the first 40 acres will be completed this summer, with an option at year-end on the remaining land. Now occupying 30,000 sf of Cary lab and office space and 110,000 sf of RTP manufacturing space, Diosynth currently has 600 Triangle employees.